Clinical Trial Update: Intravenous Immunoglobulins in Complex-regional Pain Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial of intravenous immunoglobulins for Complex Regional Pain Syndrome Type 1 was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome Type 1

Snippet

Sponsor: University of Giessen | Conditions: Complex Regional Pain Syndrome Type 1 | Phase 3 | Status: WITHDRAWN